Clinical Trial Update: Phase II Lung Metcore - Preoperative Metformin for Lung Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating preoperative metformin for lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non Small Cell Lung Cancer, Lung Cancer | Phase 2 | Status: COMPLETED